EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway

PLOS One Editors

PLOS One · 04.08.2026 · 21 (8) · e0355259

DOI: 10.1371/journal.pone.0355259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 04.08.2026. Verfasst von PLOS One Editors. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following the publication of this article [1], concerns were raised about Figs 2, 8, 10, and the welfare of the rats used in [1].

Zitieren

APA

PLOS One Editors (2026). Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway. PLOS One, 21(8), e0355259. https://doi.org/10.1371/journal.pone.0355259

Vancouver

PLOS One Editors. Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway. PLOS One. 2026;21(8):e0355259. doi:10.1371/journal.pone.0355259

BibTeX
@article{PLOSOneEditors2026,
  author = {PLOS One Editors, PLOS One Editors},
  title = {Retraction: Tert-Butylhydroquinone Alleviates Early Brain Injury and Cognitive Dysfunction after Experimental Subarachnoid Hemorrhage: Role of Keap1/Nrf2/ARE Pathway},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0355259},
  doi = {10.1371/journal.pone.0355259}
}
Kostenlos starten →